CLARUS THERAPEUTICS HOLDINGS, INC.: interest_expense

Value{"amount": 4447000, "concept": "us-gaap:InterestExpense", "currency": "USD"}
Period2021-07-01 – 2021-09-30
Statuscurrent
EntityCLARUS THERAPEUTICS HOLDINGS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001193125-21-335251 · Open the official SEC filing →
Retrieved: 2026-08-19T18:16:51.640354+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001817944/interest-expense/2021-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/785cda3f-e1ac-4020-b369-e97d1697289f

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies